4//SEC Filing
Zovighian Bernard J 4
Accession 0001225208-25-005684
CIK 0001099800other
Filed
Jun 2, 8:00 PM ET
Accepted
Jun 3, 5:15 PM ET
Size
8.8 KB
Accession
0001225208-25-005684
Insider Transaction Report
Form 4
Zovighian Bernard J
DirectorCEO
Transactions
- Sale
Common Stock
2025-06-03$77.32/sh−967$74,772→ 8,596.551 total(indirect: By Trust) - Sale
Common Stock
2025-05-30$77.21/sh−16,099$1,243,065→ 9,563.551 total(indirect: By Trust)
Holdings
- 3,605.849(indirect: By 401(k))
Common Stock
- 80,976
Common Stock
Footnotes (3)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 28, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $76.930 to $77.585 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $77.140 to $77.540 The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001665141
Filing Metadata
- Form type
- 4
- Filed
- Jun 2, 8:00 PM ET
- Accepted
- Jun 3, 5:15 PM ET
- Size
- 8.8 KB